Your browser doesn't support javascript.
loading
Mycoplasma pneumoniae co-infection with SARS-CoV-2: A case report.
Chaudhry, Rama; Sreenath, K; Vinayaraj, E V; Sahoo, Biswajeet; Vishnu Narayanan, M R; Kiran, K V P Sai; Batra, Priyam; Rathor, Nisha; Singh, Sheetal; Mohan, Anant; Bhatnagar, Sushma.
Afiliação
  • Chaudhry R; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Sreenath K; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Vinayaraj EV; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Sahoo B; Department of Laboratory Oncology, National Cancer Institute, Jhajjar, Hayana, India.
  • Vishnu Narayanan MR; Department of Anaesthesiology, All India Institute of Medical Sciences, New Delhi, India.
  • Kiran KVPS; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Batra P; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Rathor N; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Singh S; Department of Hospital Administration, National Cancer Institute, Jhajjar, Hayana, India.
  • Mohan A; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Bhatnagar S; Department of Onco-Anaesthesia and Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
Access Microbiol ; 3(3): 000212, 2021 Mar.
Article em En | MEDLINE | ID: mdl-34151164
We report co-infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Mycoplasma pneumoniae in a patient with pneumonia in India. Atypical bacterial pathogens causing community-acquired pneumonia may share similar clinical presentations and radiographic features with SARS-CoV-2 making a thorough differential diagnosis essential. The co-infection of SARS-CoV-2 and M. pneumoniae is infrequently reported in the literature. Broader testing for common respiratory pathogens should be performed in severe COVID-19 cases to rule out other concurrent infections. Early identification of co-existing respiratory pathogens could provide pathogen-directed therapy, and can save patient lives during the ongoing COVID-19 outbreak.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article